Profile
Laurent Condomine formerly worked at Exonhit, as Chairman-Supervisory Board, Nanobiotix SA, as Chairman-Supervisory Board from 2011 to 2021, Eurobio-Scientific SA, as Chairman-Supervisory Board from 2005 to 2017, Formpart (ILG) Ltd., as Managing Director, Ici Pharma, as Chief Financial Officer & Commercial Director from 1973 to 1984, AstraZeneca PLC, as Vice President-Business Development, Imperial Chemical Industries Ltd., as Vice President-Business Development from 1992 to 1993, Applied Distribution Group Plc, as Principal, and Zeneca Garden Care, as Vice President-Business Development.
Mr. Condomine received his Masters Business Admin degree in 1970 from INSEAD and graduate degree in 1969 from École des Hautes Études Commerciales de Paris.
Former positions of Laurent Condomine
Companies | Position | End |
---|---|---|
NANOBIOTIX | Chairman | 2021-05-24 |
EUROBIO SCIENTIFIC | Chairman | 2017-06-14 |
Exonhit
Exonhit Pharmaceuticals: MajorHealth Technology Exonhit is developing and manufacturing novel pharmaceuticals from its expertise in the field of alternative RNA splicing, the process by which a single gene can lead to several proteins. The firm's proprietary gene profiling technology DATAS is utilized to identify genes whose splice variants produce abnormal proteins which may trigger or contribute to the development of disease. The company was founded in 1997 and is headquartered in Paris, France. | Chairman | 2012-12-19 |
ASTRAZENECA PLC | Corporate Officer/Principal | 2007-12-31 |
Imperial Chemical Industries Ltd.
Imperial Chemical Industries Ltd. Chemicals: Major DiversifiedProcess Industries Imperial Chemical Industries Ltd. manufactures chemicals and paint products. Its products include coatings, adhesives, starch, and synthetic polymer. The company was founded on December 7, 1926 and is headquartered in Slough, the United Kingdom. | Corporate Officer/Principal | 1992-12-31 |
Training of Laurent Condomine
INSEAD | Masters Business Admin |
École des Hautes Études Commerciales de Paris | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
ASTRAZENECA PLC | Health Technology |
NANOBIOTIX | Health Technology |
EUROBIO SCIENTIFIC | Health Technology |
Private companies | 6 |
---|---|
Imperial Chemical Industries Ltd.
Imperial Chemical Industries Ltd. Chemicals: Major DiversifiedProcess Industries Imperial Chemical Industries Ltd. manufactures chemicals and paint products. Its products include coatings, adhesives, starch, and synthetic polymer. The company was founded on December 7, 1926 and is headquartered in Slough, the United Kingdom. | Process Industries |
Applied Distribution Group Plc
Applied Distribution Group Plc Air Freight/CouriersTransportation Applied Distribution Group Plc was previously engaged in providing logistics and third-party contract distribution services to retailers and manufacturers. The company was acquired by Tibbett & Britten Group in 1997 and now fully integrated within Tibbett & Britten Group. Applied Distribution Group was headquartered in Maidstone, UK | Transportation |
Formpart (ILG) Ltd.
Formpart (ILG) Ltd. Internet Software/ServicesTechnology Services Formpart (ILG) Ltd. provides historical data of a broad range of chemicals to the petrochemical and energy industries. The company is based in Sutton, UK. Formpart (ILG was acquired by Reed Business Information Ltd. on February 01, 1994. | Technology Services |
Zeneca Garden Care
Zeneca Garden Care Pharmaceuticals: OtherHealth Technology Part of AstraZeneca PLC, Zeneca Garden Care is a British company that develops and manufactures pharmaceutical products, agrochemicals, and specialty chemicals. The company is based in Macclesfield, UK. Zeneca Garden Care was acquired by Zeneca Group Plc on January 01, 1995 for $84.16 million. | Health Technology |
Exonhit
Exonhit Pharmaceuticals: MajorHealth Technology Exonhit is developing and manufacturing novel pharmaceuticals from its expertise in the field of alternative RNA splicing, the process by which a single gene can lead to several proteins. The firm's proprietary gene profiling technology DATAS is utilized to identify genes whose splice variants produce abnormal proteins which may trigger or contribute to the development of disease. The company was founded in 1997 and is headquartered in Paris, France. | Health Technology |
Ici Pharma |
- Stock Market
- Insiders
- Laurent Condomine